期刊文献+

原发性巨球蛋白血症15例 被引量:4

Clinical analysis of 15 patients with Waldenstrom' s macroglobulinemia
原文传递
导出
摘要 目的探讨原发性巨球蛋白血症(WM)的临床特点。方法回顾性分析15例患者临床表现、免疫表型及治疗。结果3例完全缓解(CR),9例部分缓解(PR),7例生存,病程最长达79个月。结论WM传统的诊断方法不够完善,免疫表型能够更进一步明确诊断。在治疗方面,WM是不能治愈性疾病,但经积极治疗生存期可延长,应考虑化疗并血浆置换联合治疗。 Objective To investigate the diagnosis and treatment of Waldenstrom's macroglobulinemia (WM). Methods The clinical information of 15 patients with WM were analyzed retrospectively. Results 3 cases had achieved complete response (CR). 9 cases had achieved partial response (PR). 7 cases remained alive, one of them lived beyond 79 months. Conclusion The traditional diagnosis of WM is not enough, and immunophenotype described for WM diagnosis is more important. WM is an incurable disease. Treatment with plasmapheresis and chemotheraov appears highly effective and safe for WM.
出处 《白血病.淋巴瘤》 CAS 2008年第6期433-435,438,共4页 Journal of Leukemia & Lymphoma
关键词 WALDENSTROM巨球蛋白血症 诊断 治疗 Waldenstrom macroglobulinemia Diagnosis Therapy
  • 相关文献

参考文献17

  • 1Gertz MA, Fonseca R, Rajkumar SV. Waldenstrom's macroglobulinemia[J]. Oncologist, 2000, 5(1): 63-67.
  • 2Garcia-Sanz R, Montoto S, Torrequebrada A, et al, Waldenstrom macroglobulinaemia: presenting features and outcome in a series with 217 cases[J]. Br J Haematol, 2001, 115(3): 575-582.
  • 3Owen RG, Treon SP, Al-Katib A, et al .Clinicopathological definition of Waldenstrom's maeroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Maeroglobulinemia[J]. Semin Oneol, 2003, 30(2): 110-115.
  • 4Owen RG, Barrans SL, Richards SJ, et al. Waldenstrom macroglobulinemia. Development of diagnostic criteria and identification of prognostic factors[J]. Am J Clin Pathol, 2001, 116 (3): 420-428.
  • 5Konoplev S, Medeiros LJ, Bueso-Ramos CE, et al. Immunophenotypic profile of lymphoplasmacytic lymphoma/ Waldenstrom macroglobulinemia[J]. Am J Clin Pathol, 2005, 124 (3): 414-420.
  • 6Ocio EM, Schop RF, Gonzalez B, et al. 6q deletion in Waldenstrom macroglobulinemia is associated with features of adverse prognosis [J]. Br J Haematol, 2007, 136(1): 80-86.
  • 7Anagnostopoulos A, Zervas K, Kyrtsonis M, et al. Prognostic value of serum beta2-microglobulin in patients with Waldenstrom's macroglobulinemia requiring treatment [J]. Clin Lymphoma Myeloma, 2006, 7(3): 205-209.
  • 8Ghobrial IM, Fonseca R, Gertz MA, et al. Prognostic model for disease -specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom maeroglobulinaemia[J]. Br J Haematol, 2006, 133(2): 158-164.
  • 9Tamburini J, Levy V, Chaleteix C, et al. Fludarabine plus eyclophosphamide in Waldenstrom's macroglobulinemia: results in 49 patients[J]. Leukemia, 2005, 19(10): 1831-1834.
  • 10Weber DM, Dimopoulos MA, Delasalle K, et al. 2- Chlorodeoxyadenosine alone and in combination for previously untreated Waldenstrom's macroglobulinemia[J]. Semin Oncol, 2003, 30(2): 243-247.

同被引文献26

  • 1孙丽霞,王金铠.原发性巨球蛋白血症的诊治进展[J].临床荟萃,2006,21(6):439-441. 被引量:6
  • 2陈心传,勾红峰,徐才刚.华氏巨球蛋白血症22例临床分析[J].四川医学,2007,28(2):161-163. 被引量:3
  • 3王晓燕,季林祥,杨仁池.Waldenstrom巨球蛋白血症24例临床分析[J].白血病.淋巴瘤,2007,16(1):30-32. 被引量:4
  • 4Owen RG,Treon SP,Alkatib A,et al.Clinicopathological definition of waldenstrSm macroglobulinemia:consensus panel recommendations from the second international workshop on Waldenstrom marroglobulinemia.Semi Oncol,2003,30:110-115.
  • 5Swerdlow SH,Berger F,Pileri SA,et al.Lymphoplasmacytic lymphoma// Swerdlow SH,Campo E,Harris NL,et al.WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues.4th ed.Lyon:IARC Press,2008:194-195.
  • 6Viswanatha D,Foucar K.Hodgkin and non-Hodgkin lymphoma involving bone marrow.Semi Diagn Pathol,2003,20:196-210.
  • 7Vijay A.Gertz MA.Waldenstr(o)m macroglobulinemia.Blooa,2007,109:5096-5103.
  • 8Lin P,Medeiros LJ.Lymphoplasmacytic lymphoma/Waldenstr(o)m macroglobulinemia-an evolving concept.Adv Anat Pathol,2005,12:246-255.
  • 9Berger F,Isaacson PC,Piris MA,et al.Lymphoplasmacytic lymphoma/waldenstr(o)m macroglobulinemia// Jaffe ES,Harris NL,Stein,et al.World Health Organization Classification of Tumors-Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues.3th ed.Lyon:IARC Press,2001.
  • 10Morice WG,Chen D,Kurtin PJ,et al.Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with waldenstr?m macroglobulinemia.Mod Pathol,2009,22:807-816.

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部